What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Alzheimer's disease
His primary areas of investigation include Psychiatry, Alzheimer's disease, Internal medicine, Dementia and Placebo.
Alzheimer's disease is the subject of his research, which falls under Disease.
His Disease research is multidisciplinary, relying on both Natural history and Neuroscience.
His research on Internal medicine frequently connects to adjacent areas such as Surgery.
His Dementia study combines topics in areas such as Pharmacotherapy, Confidence interval, Geriatrics and Quality of life.
His Placebo research incorporates themes from Anesthesia, Galantamine, Central nervous system disease and Endocrinology.
His most cited work include:
- Dementia prevention, intervention, and care (2073 citations)
- A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease (2070 citations)
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria (1750 citations)
What are the main themes of his work throughout his whole career to date?
Lon S. Schneider mostly deals with Disease, Psychiatry, Internal medicine, Clinical trial and Alzheimer's disease.
His Disease study integrates concerns from other disciplines, such as Gerontology, Cognition, Neuroscience, Intensive care medicine and Biomarker.
His Psychiatry study combines topics from a wide range of disciplines, such as Dementia and Clinical psychology.
Lon S. Schneider works mostly in the field of Internal medicine, limiting it down to topics relating to Placebo and, in certain cases, Randomized controlled trial, Adverse effect, Tolerability and Anesthesia, as a part of the same area of interest.
His Clinical trial research is multidisciplinary, incorporating elements of Memantine, Physical medicine and rehabilitation, Cholinesterase, Drug development and Physical therapy.
His Alzheimer's disease study incorporates themes from MEDLINE, Pharmacology, Cognitive disorder and Cognitive decline.
He most often published in these fields:
- Disease (31.91%)
- Psychiatry (30.93%)
- Internal medicine (29.57%)
What were the highlights of his more recent work (between 2014-2021)?
- Disease (31.91%)
- Clinical trial (27.43%)
- Internal medicine (29.57%)
In recent papers he was focusing on the following fields of study:
Disease, Clinical trial, Internal medicine, Alzheimer's disease and Dementia are his primary areas of study.
His Disease research incorporates elements of Biomarker and Neuroimaging, Cognition, Neuroscience.
His research integrates issues of Psychological intervention, Observational study, Physical medicine and rehabilitation and Adverse effect, Pharmacology in his study of Clinical trial.
In his research on the topic of Internal medicine, Tolerability is strongly related with Placebo.
He has included themes like Psychiatry, Psychomotor agitation, Gerontology, Citalopram and Cognitive decline in his Alzheimer's disease study.
Lon S. Schneider has researched Dementia in several fields, including MEDLINE, Intervention, Family medicine, Intensive care medicine and Cohort.
Between 2014 and 2021, his most popular works were:
- Dementia prevention, intervention, and care (2073 citations)
- Defeating Alzheimer's disease and other dementias: a priority for European science and society (768 citations)
- Analysis of shared heritability in common disorders of the brain (726 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Alzheimer's disease
The scientist’s investigation covers issues in Disease, Alzheimer's disease, Dementia, Clinical trial and Internal medicine.
His Disease research incorporates themes from Psychiatry, Cognition, Neuroscience, Intensive care medicine and Biomarker.
His Psychiatry research is multidisciplinary, incorporating perspectives in Number needed to treat and Quality of life.
His research integrates issues of Placebo and Gerontology in his study of Alzheimer's disease.
Lon S. Schneider has researched Clinical trial in several fields, including Adverse effect, Pharmacology, Urinary system and Randomized controlled trial.
His work in Internal medicine tackles topics such as Oncology which are related to areas like Positron emission tomography.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
